At therapeutic doses, most women lose four to eight pounds per month
In the United States, prescribing information for all medications licensed for obesity that act on the CNS, including the GLP-1RAs liraglutide 3 mg (Saxenda) and semaglutide 2.4 mg (Wegovy), must include the recommendation of monitoring for depression and suicidal ideation 231
Potential Metabolic Support GLP-1 medications are known to help regulate blood sugar levels, which may benefit individuals dealing with insulin resistance or metabolic slowdown
When youre talking about two, three, four hundred dollars a month, (for) a lot of people, you know, that is just impossible. Ur said generics should theoretically be the same as the brand name, but occasionally patients dont have as good a response to generic medications so may decide to stay with the original
Recently, Archer et al
Expanding research in this area will be crucial for developing targeted treatments to mitigate the burden of cognitive impairment in diabetes